Immunogenicity, Safety, and Predictors of Response After a Pneumococcal Conjugate and Pneumococcal Polysaccharide Vaccine Series in Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy

Autor:	John Marcinak, Mark J. Abzug, Terence Fenton, Stephen I. Pelton, William Borkowsky, Lin-Ye Song, Indu Pathak, Sharon Nachman, Howard M. Rosenblatt, Elaine J. Abrams, Arry Dieudonne, Myron J. Levin
Rok vydání:	2006
Předmět:	Male Microbiology (medical) Heptavalent Pneumococcal Conjugate Vaccine Adolescent Statistics as Topic Enzyme-Linked Immunosorbent Assay HIV Infections Meningococcal Vaccines Meningococcal vaccine Pneumococcal Infections Pneumococcal conjugate vaccine Pneumococcal Vaccines Antiretroviral Therapy Highly Active medicine Humans Child business.industry Immunogenicity medicine.disease Antibodies Bacterial Pneumococcal polysaccharide vaccine CD4 Lymphocyte Count Vaccination Pneumococcal infections Streptococcus pneumoniae Infectious Diseases Pneumococcal vaccine Child Preschool Pediatrics Perinatology and Child Health Immunology RNA Viral Female business medicine.drug
Zdroj:	The Pediatric Infectious Disease Journal. 25:920-929
ISSN:	0891-3668
DOI:	10.1097/01.inf.0000237830.33228.c3
Popis:	Background: The immunogenicity and safety of 2 doses of pneumococcal conjugate vaccine (PCV) and 1 dose of pneumococcal polysaccharide vaccine (PPV) were evaluated in human immunodeficiency virus (HIV)-infected children receiving highly active antiretroviral therapy (HAART). Methods: Children 2 to
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df6721ff973fd933e9a752c55a566746 https://doi.org/10.1097/01.inf.0000237830.33228.c3 Zobrazit plný text záznamu